- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 30, 2025 | 3.26M sh |
| Short Term Investments | Q3 2025 · Mar 31, 2025 | $5.42M |
| Short Term Investments | Q3 2025 · Jun 30, 2024 | $4.22M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $33K |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $45K |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $18.32M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $12.89M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $28.99M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $21.61M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $49.94M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $36.61M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $64.27M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $52.48M |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 3.52M sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 3.6M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $1.83M |
| Capex | Q3 2025 · Mar 31, 2024 | $876K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $5.18M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $30.94M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $31.79M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $31.59M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.19 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.15 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.15 |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $760K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $2.35M |
| Net Income | Q3 2025 · Mar 31, 2024 | $655K |
| Net Income | Q3 2025 · Mar 31, 2024 | $540K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $2.21M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $4.82M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $4M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $10.46M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $10.29M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $28.36M |
| Revenue | Q3 2025 · Mar 31, 2024 | $14.29M |
| Revenue | Q3 2025 · Mar 31, 2024 | $38.82M |